Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 1999 March;45(1) > Minerva Gastroenterologica e Dietologica 1999 March;45(1):59-76

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

A Journal on Gastroenterology, Nutrition and Dietetics


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

THERAPEUTICAL NOTES  


Minerva Gastroenterologica e Dietologica 1999 March;45(1):59-76

language: Italian

Topical beclomethasone dipropionate (BDP) in intestinal inflammatory diseases: the results of a multicentre trial

Borzio M., Borzio F., Milano G., Biraghi M., Cestari L., Ravelli P., de Franchis R., Vecchi M., Minoli G., Prada A., Curzio M., Galeone M., Toti G. L., Cacioli D., Megevand J.


Full text temporarily not available online. Contact us  


The authors assessed the efficacy and tolerability of BDP in an open protocol using rectal enemas and suppositories and in a double-blind protocol vs mesalazine using rectal enemas. A total of 47 patients suffering from ulcerous rectocolitis were enrolled in the study and treated for 42 days while undergoing endoscopic, histologic and clinical controls. In conclusion, the authors affirm that BDP may represent a useful new therapeutic instrument in the treatment of slight to moderately severe forms of inflammatory intestinal disease.

top of page

Publication History

Cite this article as

Corresponding author e-mail